CC
ENFN

Centiva Capital’s Enfusion, Inc. ENFN Stock Holding History

Centiva Capital’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,596
Closed -$243K – 2545
2024
Q3 		$243K Buy
25,596
+1,227
+5% +$10.6K ﹤0.01% 1709
2024
Q2 		$208K Buy
+24,369
New +$223K ﹤0.01% 1670

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $514M AUM 4.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $550M AUM 11.23% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $213M AUM 42.16% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Centiva Capital's ENFN Position: Q4 2024 in Review

Centiva Capital sold out of Enfusion, Inc. (ENFN) in Q4 2024, closing a stake of 25,596 shares — an estimated $243K sold.

Centiva Capital first reported a position in ENFN in Q2 2024 and held it in 2 quarters. The position peaked at $243K in Q3 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q4 2024.

  • Centiva Capital reported no remaining Enfusion, Inc. position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 25,596 Enfusion, Inc. shares in Q4 2024, an estimated $243K.
  • Centiva Capital first reported a position in Enfusion, Inc. in Q2 2024 and held it in 2 quarters.
  • Centiva Capital's Enfusion, Inc. position peaked at $243K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.